^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MEM-288

    i
    Other names: MEM-288, MEM288
    Associations
    News
    Trials
    Company:
    Memgen, Moffitt Cancer Center
    Drug class:
    CD40L stimulant, IFNβ stimulant
    Related drugs:
    Associations
    News
    Trials